期刊文献+

乳腺癌C-erbB-2表达与临床病理特征相关性分析 被引量:3

Correlation of C - erbB - 2 Status and Histologic Features in 1 6 3 Invasive Breast Carcinomas of baoji area
原文传递
导出
摘要 目的研究乳腺癌C—erbB-2、ER、PR的表达情况,C—erbB-2及激素受体与乳腺癌分级的相关性以及C-erbB-2的表达与激素受体相关性的确切程度。方法应用免疫组化法、荧光Fish法检测163例浸润性乳腺癌组织中C.erbB-2、ER、PR的表达,统计分析C—erbB-2与ER、PR的表达及组织学分级的相关性。结果163例浸润性乳腺癌组织中C-erbB-2、ER、PR表达率分别为21.5%、64.4%、44.2%,5例黏液癌、3例小管癌、1例微乳头状癌均100.0%,ER不表达;C—erbB-2在Ⅰ级乳腺癌中不表达,Ⅱ级为22.3%,Ⅲ级为27,0%。ER的表达与组织学分级呈负相关。ER、PR阳性表达率在C.erbB-2阳性的病例中明显下降。C-erbB-2阳性的病例中有少部分ER、PR阳性表达。结论浸润性乳腺癌中只有少部分表达C—erbB-2。组织学级别可以提示ER的表达,级别高者ER的表达率低,而Ⅰ级癌大多会表达ER。C-erbB-2的过表达及扩增主要在Ⅱ.Ⅲ级癌中。C—erbB一2与ER、PR的表达呈明显的负相关性。 Objective To study the relationship between C-erbB-2 and estrogen (ER) and progesterone (PR) receptors,and the relationship between C-erbB-2,ER,PR with histologic grade. Methods To detect ER,PR and C-erbB-2 states by using immunohistochemical analysis and fluorescence in situ hybridization for C-erbB-2 in 163 unselected invasive breast carcinomas. Results C-erbB-2, ER, PR were expressed in 21.5% ,64.4% ,44.2% of 163 cases respectivly . 5 pure mucinous carcinomas , 3 tubular carcinomas and 1 micropapillary carcinoma were ER + ( 100. 0% ) ,C-erbB-2 - ( 100.0% ) and PR + (40.0% ,66. 7%, 100.0% ). C-erbB-2 was positive in 22.3% of gradeⅡand 27.0% of grade Ⅲ invasive ductal carcinomas and negative in all grade Ⅰ invasive ductal carcinomas. ER and PR expression were decreased significantly in C-erbB-2 + tumors compared with C-erbB-2 - tumors (ER, 25.7%vs 75.0% ;PR,25.7% vs 49.2% ). Although ER or PR expression is decreased in C-erbB-2 + tumors,a substantial proportion of them still express ER or PR. Conclusion C-erbB-2 overexpression or amplification was limited to a minority of invasive breast carcinomas. Tumour grade was an independent predictor for ER expression. ER was expressed in small number of high-grade and in large number of gradeⅠinvasive ductal carcinomas. C-erbB-2 overexpression or amplification essentially was limited to grades Ⅱ and Ⅲductal carcinomas and correlated inversely with ER or PR expression.
出处 《中国基层医药》 CAS 2011年第15期2028-2030,共3页 Chinese Journal of Primary Medicine and Pharmacy
基金 陕西省卫生科研基金项目(编号2010C12)
关键词 乳腺肿瘤 肿瘤组织学类型 C-ERBB-2 ER PR Breast Neoplasms Neoplasms by Histological type and grade C-erbB-2 ER PR
  • 相关文献

参考文献2

二级参考文献14

共引文献6

同被引文献21

  • 1苏艳阳,孙佩杰,李娜然,孙中芙,韩丽华,杨晓霞.乳腺癌组织中癌基因c-erbB-2蛋白表达与复发、预后及其病理分型的相关性:47例单因素回顾[J].中国临床康复,2005,9(14):120-121. 被引量:1
  • 2邓君,饶绍琴,传良敏.C-ERBB2基因表达和其它肿瘤标志物在乳腺癌诊断中的应用[J].实用医院临床杂志,2006,3(1):94-95. 被引量:4
  • 3魏兵,步宏,陈卉娇,张红英,李新军.乳腺实体型乳头状癌的临床病理研究[J].中华病理学杂志,2006,35(10):589-593. 被引量:26
  • 4Maluf HM, Koemer FC. Solid papillary carcinoma of the breast. Aform of intraductal carcinoma with endocrine differentiation fre-quently associated with mucinous carcinoma. Am J Surg Pathol,1995,19(11) :1237-1244.
  • 5Cross AS,Azzopardi JG,Krausz T,et ai. Morphological and immu-nocytochemical study shof a diatinctive variant of ductal carcinomain situ of the breast. Histopathology 1985 ,9(1) :21-37.
  • 6Tan PH, Lui GG, Chiang G, et al. Ductal carcinoma in situ withspindle cells a potential diagnostic pilfall in the evaluation of breastlesions. Histopathology, 2004,45 (4) : 343-351.
  • 7Tavassoli FA, Devilee P. Pathology and genetics of tumors of thebreast and female genital organs. Lyon,IARSC Press,2003 :48-50.
  • 8Takehana T,Kunitomo K,Kono K,et al.Status of c-erbB-2 in gastric adenocarcinoma:a comparative study of immunohistochemistry,fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay.Int J Cancer,2002,98(6):833-837.
  • 9Eccles SA.The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis.J Mammary Gland Biol Neoplasia,2001,6(4):393-406.
  • 10Vaisman N,Nissim A,Klapper LN,et al.Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library.Immunol Lett,2000,75 (1):61-67.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部